These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31007801)

  • 1. Combination of a leadless pacemaker and subcutaneous implantable cardioverter defibrillator therapy for a Japanese patient with prosthetic valve endocarditis.
    Ito R; Kondo Y; Winter J; Hayashi T; Nakano M; Kajiyama T; Nakano M; Kobayashi Y
    J Arrhythm; 2019 Apr; 35(2):311-313. PubMed ID: 31007801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful intermuscular implantation of subcutaneous implantable cardioverter defibrillator in a Japanese patient with pectus excavatum.
    Kondo Y; Ueda M; Winter J; Nakano M; Nakano M; Ishimura M; Miyazawa K; Tateno K; Kobayashi Y
    J Arrhythm; 2017 Feb; 33(1):63-65. PubMed ID: 28217231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous Leadless Pacemaker and Subcutaneous ICD Implantation With Intraoperative Screening: Workflow in Two Patients.
    Nieves J; Laslett DB; Basil A; Whitman IR; Cooper JM; Cronin EM
    JACC Case Rep; 2022 Dec; 4(23):101535. PubMed ID: 36507298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined leadless pacemaker and subcutaneous implantable defibrillator therapy: feasibility, safety, and performance.
    Tjong FV; Brouwer TF; Smeding L; Kooiman KM; de Groot JR; Ligon D; Sanghera R; Schalij MJ; Wilde AA; Knops RE
    Europace; 2016 Nov; 18(11):1740-1747. PubMed ID: 26941338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator.
    Tjong FVY; Brouwer TF; Koop B; Soltis B; Shuros A; Schmidt B; Swackhamer B; Quast AEB; Wilde AAM; Burke MC; Knops RE
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1487-1498. PubMed ID: 29759829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous leadless pacemaker and subcutaneous implantable cardioverter-defibrillator implantation-When vascular options have run out.
    Ng JB; Chua K; Teo WS
    J Arrhythm; 2019 Feb; 35(1):136-138. PubMed ID: 30805055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term performance of a novel communicating antitachycardia pacing-enabled leadless pacemaker and subcutaneous implantable cardioverter-defibrillator system: A comprehensive preclinical study.
    Breeman KTN; Swackhamer B; Brisben AJ; Quast ABE; Carter N; Shuros A; Soltis B; Koop BE; Burke MC; Wilde AAM; Tjong FVY; Knops RE
    Heart Rhythm; 2022 May; 19(5):837-846. PubMed ID: 35066181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and rationale of the MODULAR ATP global clinical trial: A novel intercommunicative leadless pacing system and the subcutaneous implantable cardioverter-defibrillator.
    Lloyd MS; Brisben AJ; Reddy VY; Blomström-Lundqvist C; Boersma LVA; Bongiorni MG; Burke MC; Cantillon DJ; Doshi R; Friedman PA; Gras D; Kutalek SP; Neuzil P; Roberts PR; Wright DJ; Appl U; West J; Carter N; Stein KM; Mont L; Knops RE
    Heart Rhythm O2; 2023 Jul; 4(7):448-456. PubMed ID: 37520021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.
    Essandoh MK; Portillo JG; Weiss R; Otey AJ; Zuleta-Alarcon AN; Humeidan ML; Torres JL; Flores AS; Castellon-Larios K; Abdel-Rasoul M; Andritsos MJ; Perez WJ; Stein EJ; Turner KR; Dimitrova GT; Awad H; Bhandary SP; Tripathi RS; Joseph NC; Hummel JD; Augostini RS; Kalbfleisch SJ; Tyler JD; Houmsse M; Daoud EG
    J Clin Anesth; 2016 Jun; 31():53-9. PubMed ID: 27185678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nontransvenous Cardiovascular Implantable Electronic Device Technology-A Review for the Anesthesiologist.
    Cody J; Graul T; Holliday S; Streckenbach S; Hussain N; Dalia AA; Cronin B; Hargrave J; Augoustides JG; Essandoh M
    J Cardiothorac Vasc Anesth; 2021 Sep; 35(9):2784-2791. PubMed ID: 33707106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of a leadless pacemaker and subcutaneous defibrillator with nine effective shock treatments during follow-up of 18 months.
    Ljungström E; Brandt J; Mörtsell D; Borgquist R; Wang L
    J Electrocardiol; 2019; 56():1-3. PubMed ID: 31226509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Totally Leadless Dual-Device Implantation for Combined Spontaneous Ventricular Tachycardia Defibrillation and Pacemaker Function: A First Report.
    Ahmed FZ; Cunnington C; Motwani M; Zaidi AM
    Can J Cardiol; 2017 Aug; 33(8):1066.e5-1066.e7. PubMed ID: 28754393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review of Short-Term Outcomes of Leadless Pacemaker Implantation After Transvenous Lead Removal of Infected Cardiac Implantable Electronic Device.
    Tan MC; Tan JL; Tay ST; Sorajja D; Scott L; Cha YM; Russo AM; Hussein A; Lee JZ
    Am J Cardiol; 2023 Sep; 203():444-450. PubMed ID: 37542954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of leadless pacemaker positioning in relation to subcutaneous implantable cardioverter-defibrillator sensing in completely leadless cardiac resynchronization and defibrillation systems.
    Elliott MK; Sidhu BS; Mehta VS; Gould J; Martic D; Rinaldi CA
    HeartRhythm Case Rep; 2021 Sep; 7(9):628-632. PubMed ID: 34552857
    [No Abstract]   [Full Text] [Related]  

  • 15. Leadless Cardiac Devices-Pacemakers and Implantable Cardioverter-Defibrillators.
    Rutzen-Lopez H; Silva J; Helm RH
    Curr Treat Options Cardiovasc Med; 2016 Aug; 18(8):49. PubMed ID: 27287746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The modular cardiac rhythm management system: the EMPOWER leadless pacemaker and the EMBLEM subcutaneous ICD.
    Tjong FVY; Koop BE
    Herzschrittmacherther Elektrophysiol; 2018 Dec; 29(4):355-361. PubMed ID: 30382341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defibrillators: Selecting the Right Device for the Right Patient.
    Al-Khatib SM; Friedman P; Ellenbogen KA
    Circulation; 2016 Nov; 134(18):1390-1404. PubMed ID: 27799257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is hybrid subcutaneous implantable cardioverter-defibrillator and leadless pacemaker the future of device therapy?
    Liang J; Cha Y
    Int J Cardiol; 2017 May; 235():201. PubMed ID: 28342500
    [No Abstract]   [Full Text] [Related]  

  • 19. The need for a subsequent transvenous system in patients implanted with subcutaneous implantable cardioverter-defibrillator.
    Gasperetti A; Schiavone M; Vogler J; Laredo M; Fastenrath F; Palmisano P; Ziacchi M; Angeletti A; Mitacchione G; Kaiser L; Compagnucci P; Breitenstein A; Arosio R; Vitali F; De Bonis S; Picarelli F; Casella M; Santini L; Pignalberi C; Lavalle C; Pisanò E; Ricciardi D; Calò L; Curnis A; Bertini M; Gulletta S; Dello Russo A; Badenco N; Tondo C; Kuschyk J; Tilz R; Forleo GB; Biffi M
    Heart Rhythm; 2022 Dec; 19(12):1958-1964. PubMed ID: 35781042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant Use of the Subcutaneous Implantable Cardioverter Defibrillator and a Permanent Pacemaker.
    Huang J; Patton KK; Prutkin JM
    Pacing Clin Electrophysiol; 2016 Nov; 39(11):1240-1245. PubMed ID: 27734502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.